Bacillus anthracis is surrounded by an antiphagocytic capsule that is composed of poly-gamma-D-glutamic acid (PGA). Despite an essential role for the capsule in the pathogenesis of anthrax, the immune response to the capsule has received little attention, and the protective role of PGA antibody is unknown. The overall hypothesis for this proposal is that PGA antibodies are protective against anthrax. The goal for the study is to generate a library of PGA monoclonal antibodies (mAbs) and to evaluate the properties of the antibodies in vitro and in vivo. In preliminary studies, a strong isotype-switched (IgG) and affinity-matured antibody response has been generated in mice through immunization with PGA in combination with a potent and novel B-cell adjuvant. Five hybridomas that secrete anti-PGA IgG have been generated in a very short time, and production of additional mAbs having distinct epitope specificities is in progress. Thus, the feasibility for generation of a robust antibody response in mice and for production of lgG mAbs has been demonstrated.
The specific aims of the proposal are to i) generate a library of PGA IgG mAbs that represent a spectrum of epitope specificities, ii) evaluate the immunochemistry of mAb binding to soluble and capsular PGA, iii) generate IgG subclass switch variants of PGA mAbs, iv) assess in vitro activities of PGA mAbs that may be predictive of protection, and v) evaluate the role of epitope specificity and antibody isotype in determining protection in murine models of cutaneous and inhalation anthrax. Targeting the capsule for vaccine development or immunotherapy is attractive because anticapsularimmunity would not be compromised by antibiotic resistance or engineering of an anthrax toxin that is resistant to toxin-based immunity. The proposed determination of protective efficacy is central to any effort at active or passive immunization that targets the B. anthracis capsule and would provide proof of concept for passive immunization as a pre- or post-exposure immunotherapy for anthrax.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI059348-01
Application #
6703838
Study Section
Special Emphasis Panel (ZRG1-SSS-F (05))
Program Officer
Baker, Phillip J
Project Start
2004-06-01
Project End
2007-05-31
Budget Start
2004-06-01
Budget End
2005-05-31
Support Year
1
Fiscal Year
2004
Total Cost
$445,894
Indirect Cost
Name
University of Nevada Reno
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
146515460
City
Reno
State
NV
Country
United States
Zip Code
89557
Gates-Hollingsworth, Marcellene A; Perry, Mark R; Chen, Hongjing et al. (2015) Immunoassay for Capsular Antigen of Bacillus anthracis Enables Rapid Diagnosis in a Rabbit Model of Inhalational Anthrax. PLoS One 10:e0126304
Hovenden, Maria; Hubbard, Mark A; Aucoin, David P et al. (2013) IgG subclass and heavy chain domains contribute to binding and protection by mAbs to the poly ?-D-glutamic acid capsular antigen of Bacillus anthracis. PLoS Pathog 9:e1003306
Hubbard, Mark A; Thorkildson, Peter; Welch, William H et al. (2013) Stereo-selective binding of monoclonal antibodies to the poly-?-D-glutamic acid capsular antigen of Bacillus anthracis. Mol Immunol 55:337-44
Hubbard, Mark A; Thorkildson, Peter; Kozel, Thomas R et al. (2013) Constant domains influence binding of mouse-human chimeric antibodies to the capsular polypeptide of Bacillus anthracis. Virulence 4:483-8
AuCoin, David P; Reed, Dana E; Marlenee, Nicole L et al. (2012) Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei. PLoS One 7:e35386
AuCoin, David P; Crump, Reva B; Thorkildson, Peter et al. (2010) Identification of Burkholderia cepacia complex bacteria with a lipopolysaccharide-specific monoclonal antibody. J Med Microbiol 59:41-7
Boyer, Anne E; Quinn, Conrad P; Hoffmaster, Alex R et al. (2009) Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques. Infect Immun 77:3432-41
AuCoin, David P; Sutherland, Marjorie D; Percival, Ann L et al. (2009) Rapid detection of the poly-gamma-D-glutamic acid capsular antigen of Bacillus anthracis by latex agglutination. Diagn Microbiol Infect Dis 64:229-32
Vlassiouk, Ivan; Kozel, Thomas R; Siwy, Zuzanna S (2009) Biosensing with nanofluidic diodes. J Am Chem Soc 131:8211-20
Sutherland, Marjorie D; Kozel, Thomas R (2009) Macrophage uptake, intracellular localization, and degradation of poly-gamma-D-glutamic acid, the capsular antigen of Bacillus anthracis. Infect Immun 77:532-8

Showing the most recent 10 out of 13 publications